pubmed-article:12438291 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:12438291 | lifeskim:mentions | umls-concept:C0008976 | lld:lifeskim |
pubmed-article:12438291 | lifeskim:mentions | umls-concept:C0018801 | lld:lifeskim |
pubmed-article:12438291 | lifeskim:mentions | umls-concept:C0019010 | lld:lifeskim |
pubmed-article:12438291 | lifeskim:mentions | umls-concept:C0597357 | lld:lifeskim |
pubmed-article:12438291 | lifeskim:mentions | umls-concept:C0079284 | lld:lifeskim |
pubmed-article:12438291 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
pubmed-article:12438291 | lifeskim:mentions | umls-concept:C0018837 | lld:lifeskim |
pubmed-article:12438291 | lifeskim:mentions | umls-concept:C0264716 | lld:lifeskim |
pubmed-article:12438291 | lifeskim:mentions | umls-concept:C0332206 | lld:lifeskim |
pubmed-article:12438291 | pubmed:dateCreated | 2002-11-19 | lld:pubmed |
pubmed-article:12438291 | pubmed:abstractText | The endothelin (ET-1) system is activated in chronic heart failure (CHF). Whether, what type, and what degree of selective ET blockade is clinically beneficial is unknown. We investigated hemodynamic and neurohumoral effects of 3 weeks of treatment with various dosages of the orally available ET(A) antagonist darusentan in addition to modern standard therapy in patients with CHF. | lld:pubmed |
pubmed-article:12438291 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12438291 | pubmed:language | eng | lld:pubmed |
pubmed-article:12438291 | pubmed:citationSubset | AIM | lld:pubmed |
pubmed-article:12438291 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12438291 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12438291 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12438291 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12438291 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12438291 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12438291 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:12438291 | pubmed:author | pubmed-author:LüscherThomas... | lld:pubmed |
pubmed-article:12438291 | pubmed:author | pubmed-author:DietzRainerR | lld:pubmed |
pubmed-article:12438291 | pubmed:author | pubmed-author:RuschitzkaFra... | lld:pubmed |
pubmed-article:12438291 | pubmed:author | pubmed-author:HürlimannDavi... | lld:pubmed |
pubmed-article:12438291 | pubmed:author | pubmed-author:EnseleitFrank... | lld:pubmed |
pubmed-article:12438291 | pubmed:author | pubmed-author:NollGeorgG | lld:pubmed |
pubmed-article:12438291 | pubmed:author | pubmed-author:PhilippSebast... | lld:pubmed |
pubmed-article:12438291 | pubmed:author | pubmed-author:WillenbrockRo... | lld:pubmed |
pubmed-article:12438291 | pubmed:author | pubmed-author:PacherRichard... | lld:pubmed |
pubmed-article:12438291 | pubmed:author | pubmed-author:RoussonValent... | lld:pubmed |
pubmed-article:12438291 | pubmed:author | pubmed-author:MitrovicVesel... | lld:pubmed |
pubmed-article:12438291 | pubmed:author | pubmed-author:NotterThomasT | lld:pubmed |
pubmed-article:12438291 | pubmed:author | pubmed-author:SchulzeMatthi... | lld:pubmed |
pubmed-article:12438291 | pubmed:author | pubmed-author:Heart... | lld:pubmed |
pubmed-article:12438291 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:12438291 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:12438291 | pubmed:pagination | 2666-72 | lld:pubmed |
pubmed-article:12438291 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
pubmed-article:12438291 | pubmed:articleTitle | Hemodynamic and neurohumoral effects of selective endothelin A (ET(A)) receptor blockade in chronic heart failure: the Heart Failure ET(A) Receptor Blockade Trial (HEAT). | lld:pubmed |
pubmed-article:12438291 | pubmed:affiliation | Cardiovascular Center, Cardiology, University Hospital, Zürich, Switzerland. cardiotfl@gmx.ch | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12438291 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12438291 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12438291 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12438291 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12438291 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12438291 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12438291 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12438291 | lld:pubmed |